Journal of Medicinal Chemistry
Page 28 of 33
1
2
3
4
5
6
7
(1)
(2)
Nes, W. D. Biosynthesis of cholesterol and other sterols. Chem. Rev. 2011, 111, 6423ꢀ6451.
Koide, T.; Hayata, T.; Cho, K. W. Negative regulation of Hedgehog signaling by the
cholesterogenic enzyme 7ꢀdehydrocholesterol reductase. Development 2006, 133, 2395ꢀ2405.
(3) Lauth, M.; Rohnalter, V.; Bergstrom, A.; Kooshesh, M.; Svenningsson, P.; Toftgard, R.
Antipsychotic drugs regulate hedgehog signaling by modulation of 7ꢀdehydrocholesterol reductase levels.
8
9
Mol. pharmacol. 2010, 78, 486ꢀ496.
(4)
Stottmann, R. W.; TurbeꢀDoan, A.; Tran, P.; Kratz, L. E.; Moran, J. L.; Kelley, R. I.; Beier, D.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
R. Cholesterol metabolism is required for intracellular hedgehog signal transduction in vivo. PLoS Genet.
2011, 7, e1002224.
(5)
Herman, G. E. Disorders of cholesterol biosynthesis: prototypic metabolic malformation
syndromes. Hum. Mol. Genet. 2003, 12 Spec No 1, R75ꢀ88.
(6)
(7)
Javitt, N. B. Oxysterols: novel biologic roles for the 21st century. Steroids 2008, 73, 149ꢀ157.
Smith, D. W.; LemIi, L.; Opitz, J. M. A newly recognized syndrome of multiple congenital
anomalies. J. Pediatr. 1964, 64, 210ꢀ217.
(8)
Honda, A.; Tint, G. S.; Salen, G.; Batta, A. K.; Chen, T. S.; Shefer, S. Defective conversion of
7ꢀdehydrocholesterol to cholesterol in cultured skin fibroblasts from SmithꢀLemliꢀOpitz syndrome
homozygotes. J. Lipid Res. 1995, 36, 1595ꢀ1601.
(9)
Tint, G. S.; Seller, M.; HughesꢀBensie, R.; Batta, A. K.; Shefer, S.; Genest, D.; Irons, M.;
Elias, E.; Salen, G. Markedly increased tissue concentrations of 7ꢀdehydrocholesterol combined with low
levels of cholesterol are characteristic of the SmithꢀLemliꢀOptiz syndrome. J. Lipid Res. 1995, 36, 89ꢀ95.
(10) Kanungo, S.; Soares, N.; He, M.; Steiner, R. D. Sterol metabolism disorders and
neurodevelopment—an update. Develop. Dis. Res. Rev. 2013, 17, 197ꢀ210.
(11) Porter, F. D.; Herman, G. E. Malformation syndromes caused by disorders of cholesterol
synthesis. J. Lipid Res. 2011, 52, 6ꢀ34.
(12) Andersson, H. C.; Kratz, L.; Kelley, R. I. Desmosterolosis presenting with multiple congenital
anomalies and profound developmental delay. Am. J. Med. Genet. 2002, 113, 315ꢀ319.
(13) FitzPatrick, D. R.; Keeling, J. W.; Evans, M. J.; Kan, A. E.; Bell, J. E.; Porteous, M. E.; Mills,
K.; Winter, R. M.; Clayton, P. T. Clinical phenotype of desmosterolosis. Am. J. Med. Genet. 1998, 175, 145ꢀ
152.
(14) Schaaf, C. P.; Koster, J.; Katsonis, P.; Kratz, L.; Shchelochkov, D. A.; Scaglia, F.; Kelley, R.
I.; Lichtarge, O.; Waterham, H. R.; Shinawi, M. Desmosterolosisꢀphenotypic and molecular characterization
of a third case and review of the literature. Am. J. Med. Genet. A 2011, 155A, 1597ꢀ1604.
(15) Waterham, H. R.; J. Koster, J.; omeijn, G. J.; Hennekam, R. C.; Vreken, P.; Andersson, H. C.;
FitzPatrick, D. R.; Kelley, R. I.; J., W. R. Mutations in the 3betaꢀhydroxysterol Delta24ꢀreductase gene cause
desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet. 2001, 69,
685ꢀ694.
(16) Zolotushko, J.; Flusser, H.; Markus, B.; Shelef, I.; Langer, Y.; Heverin, M.; Bjorkhem, I.;
Sivan, S.; Birk, O. S. The desmosterolosis phenotype: spasticity, microcephaly and micrognathia with
agenesis of corpus callosum and loss of white matter. Eur. J. Hum. Genet. 2011, 19, 942ꢀ946.
(17) Haas, D.; Garbade, S. F.; Vohwinkel, C.; Muschol, N.; Trefz, F. K.; Penzien, J. M.; Zschocke,
J.; Hoffmann, G. F.; Burgard, P. Effects of cholesterol and simvastatin treatment in patients with Smithꢀ
LemliꢀOpitz syndrome (SLOS). J. Inherited Metab. Dis. 2007, 30, 375ꢀ387.
(18) Chan, Y. M.; Merkens, L. S.; Connor, W. E.; Roullet, J. B.; Penfield, J. A.; Jordan, J. M.;
Steiner, R. D.; Jones, P. J. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smithꢀ
LemliꢀOpitz syndrome. Pediatr. Res. 2009, 65, 681ꢀ685.
(19) Szabo, G. P.; Olah, A. V.; Kozak, L.; Balogh, E.; Nagy, A.; Blahakova, I.; Olah, E. A patient
with SmithꢀLemliꢀOpitz syndrome: novel mutation of the DHCR7 gene and effects of therapy with
simvastatin and cholesterol supplement. Eur. J. Pediatr. 2010, 169, 121ꢀ123.
28
ACS Paragon Plus Environment